These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Beneficial effects of two forms of NO administration in feline splanchnic artery occlusion shock. Aoki N; Johnson G; Lefer AM Am J Physiol; 1990 Feb; 258(2 Pt 1):G275-81. PubMed ID: 2305894 [TBL] [Abstract][Full Text] [Related]
43. Heterogeneity of systemic hemodynamic response to a new calcium entry blocker, nitrendipine. Fouad FM; Aboul-Khair M; Tarazi RC J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S383-6. PubMed ID: 6184573 [TBL] [Abstract][Full Text] [Related]
44. Age related antihypertensive effect of nitrendipine, a new calcium entry blocking agent. Ferrara LA; Fasano ML; Soro S Eur J Clin Pharmacol; 1985; 28(4):473-4. PubMed ID: 3161743 [TBL] [Abstract][Full Text] [Related]
45. Protective effects of a novel 21-aminosteroid during splanchnic artery occlusion shock. Johnson G; Lefer AM Circ Shock; 1990 Feb; 30(2):155-64. PubMed ID: 2311204 [TBL] [Abstract][Full Text] [Related]
47. Reduced cardiac mass by nitrendipine is dissociated from systemic or regional haemodynamic changes in rats. Kobrin I; Sesoko S; Pegram BL; Frohlich ED Cardiovasc Res; 1984 Mar; 18(3):158-62. PubMed ID: 6705007 [TBL] [Abstract][Full Text] [Related]
48. Calcium entry blockade by nitrendipine and alpha adrenergic responsiveness in vivo: comparison with noncalcium entry blocker vasodilators in absence and presence of phenoxybenzamine pretreatment. Pedrinelli R; Tarazi RC J Pharmacol Exp Ther; 1985 Jun; 233(3):636-42. PubMed ID: 2989491 [TBL] [Abstract][Full Text] [Related]
49. Protective actions of S-nitroso-N-acetylpenicillamine (SNAP) in a rat model of hemorrhagic shock. Symington PA; Ma XL; Lefer AM Methods Find Exp Clin Pharmacol; 1992 Dec; 14(10):789-97. PubMed ID: 1338473 [TBL] [Abstract][Full Text] [Related]
54. Beneficial actions of RO 15-1788, a benzodiazepine receptor antagonist, in hemorrhagic shock. Bitterman H; Lefer DJ; Lefer AM Methods Find Exp Clin Pharmacol; 1987 Jun; 9(6):341-7. PubMed ID: 3116357 [TBL] [Abstract][Full Text] [Related]
55. Beneficial effects of transforming growth factor-beta and tissue plasminogen activator in splanchnic artery occlusion and reperfusion in cats. Karasawa A; Guo JP; Ma XL; Lefer AM J Cardiovasc Pharmacol; 1991 Jul; 18(1):95-105. PubMed ID: 1719297 [TBL] [Abstract][Full Text] [Related]
56. Comparison of the acute hemodynamic effects of nifedipine with nitrendipine and a study of the electrophysiological effects of nitrendipine in man. Rutsch W; Schmutzler H J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1011-5. PubMed ID: 6085358 [TBL] [Abstract][Full Text] [Related]
58. The calcium channel blocker nitrendipine in single- and multiple-agent antihypertensive regimens: preliminary report of a multicenter study. Weber MA; Drayer JI J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1077-84. PubMed ID: 6085371 [TBL] [Abstract][Full Text] [Related]
59. Protective effect of cloricromene, a coumarine derivative, in hypovolemic hemorrhagic shock in the rat. Sturniolo R; Squadrito F; Campo GM; Vinci R; Calatroni A; Prosdocimi M; Caputi AP J Cardiovasc Pharmacol; 1991 Feb; 17(2):261-6. PubMed ID: 1709231 [TBL] [Abstract][Full Text] [Related]
60. Differential influence of the calcium antagonist nitrendipine and the vasodilator hydralazine on normal and elevated blood pressure. Knorr A; Garthoff B Arch Int Pharmacodyn Ther; 1984 Jun; 269(2):316-22. PubMed ID: 6476986 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]